07:36 AM EDT, 10/23/2025 (MT Newswires) -- Ventyx Biosciences ( VTYX ) shares were 100% higher pre-bell Thursday, a day after the company said that VTX3232 demonstrated significant reductions in cardiovascular risk factors in a phase 2 trial in patients with obesity and cardiovascular risk factors.

American Rebel ( AREB ) stock was up 33%, extending Wednesday's rally.

Genprex ( GNPX ) shares were 12% higher after the company said its research collaborators will present positive preclinical data on the use of Reqorsa gene therapy for the treatment of lung cancer at a conference taking place Oct. 22 to Oct. 26.